Identifies a small-molecule inhibitor enhancing antidepressant efficacy in a specific model, suggesting new treatment avenues.
as a potent and selective nNOS-PDZ inhibitor, providing a promising lead compound for the development of antidepressants.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: